TB Alternative Assets Ltd. has joined the biotech investing party by purchasing 3,158 shares of Regeneron Pharmaceuticals ...

If you like what we do here, forward this email to a friend. They can get this newsletter every week through a STAT+ subscription, which is 50% off through next Monday.

( NewsNation) — The interim CEO of 23andMe will face questions from lawmakers Wednesday about the DNA company’s data privacy amid a multistate lawsuit about its customers’ genetic data. The Senate ...

Maine and 27 other states are suing 23andMe to stop the bankrupt DNA-test firm from selling customers’ genetic data.

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...

A number of US states are taking legal action against the sale of 23andMe and its DNA data. A sale is only acceptable with ...